Skip to content

High Dose Versus Low Dose Oxytocin for Augmentation of Delayed Labour in Obese Women

High Dose Versus Low Dose Oxytocin for Augmentation of Delayed Labour in Obese Women: A Randomized Clinical Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03604874
Enrollment
202
Registered
2018-07-30
Start date
2018-09-01
Completion date
2021-10-19
Last updated
2022-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DELAYED LABOUR

Brief summary

Obesity is one of the biggest public health problems of the 21st century as it increases the risk of many co-morbid medical conditions. Obesity in pregnancy places women at higher risk of obstetrical complications during pregnancy, delivery and puerperium. Obesity is a risk factor for cesarean delivery, failed induction of labor and labor dystocia, and prolonged labor curves especially among women with class III obesity.

Interventions

DRUGOxytocin

intravenous infusion

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Spontaneous onset of labor. * Body mass index ≥ 30 kg/m2. * Gestational age ≥ 37 weeks. * Singleton pregnancy. * Cephalic presentation. * Reassuring fetal heart rate monitoring. * Inefficient uterine contractions during active labor * Women who will accept to participate in the study.

Exclusion criteria

* Non-reassuring fetal assessment at the time of recruitment. * Women received cervical ripening agents. * Any patients contraindicated for vaginal delivery. * Multiple gestations. * Malpresentation. * Previous cesarean delivery. * Patients with cardiac diseases, pre-eclampsia or any other medical disorders. * Fetal demise. * Intrauterine growth restriction. * Estimated fetal weight ≥ 5000 grams. * Pre-labor rupture of membranes \> 24 hours.

Design outcomes

Primary

MeasureTime frameDescription
The mean duration from oxytocin augmentation initiation to delivery12 hoursthe calculated time between oxytocin infusion till delivery

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026